Skip to main content

Affiliate disclosure: We may earn a commission if you buy through links on this site — at no extra cost to you.

Wegovy Cost Without Insurance in 2026: What You’ll Actually Pay

By the WPG editorial team at Weight Loss Provider Guide · Last verified: September 21, 2026 · Pricing reverified periodically.

Independent comparison resource for GLP-1 telehealth providers. Some links on this page are affiliate links — if you click through and enroll, we may earn a commission at no additional cost to you. Our editorial priority is accuracy and reader fit; affiliate relationships do not determine the order or emphasis of our recommendations. Full disclosure.

Wegovy cost without insurance is not one number. It’s three. The manufacturer list price is $1,349.02 per package. The official self-pay price through Novo Nordisk’s NovoCare Pharmacy is much lower: $149–$399/month depending on format and dose. The telehealth all-in price adds a monthly membership fee on top of the NovoCare-matched medication cost.

Quick fork — do you already have a Wegovy prescription?

  • Yes → NovoCare Pharmacy is your cheapest path. Jump to pen-vs-pill pricing by dose.
  • No → A full-service telehealth path is almost certainly your best move; which one depends on whether you want to try insurance first. Keep reading.
Wegovy Without Insurance: 3 Prices That Matter. Number 1: List Price ($1,349.02 — patients with insurance at full retail). Number 2: Official Self-Pay ($149–$399/month via NovoCare — uninsured and commercially insured cash-pay patients). Number 3: Telehealth All-In (NovoCare medication + provider membership fee — patients who need prescribing + clinical support). Decision guide: Already have a prescription → Official self-pay route. Need a doctor too → Telehealth route. Think insurance might still work → Coverage check first.

The right answer depends on whether you already have a prescription, whether you have commercial insurance, and whether you want to fight for coverage before going cash-pay. Wegovy is prescription-only.

The Three Prices That Actually Matter for Wegovy Cost Without Insurance

The short version: List price ($1,349.02/package), official self-pay ($149–$399/month via NovoCare), and telehealth all-in (NovoCare-matched medication + monthly membership fee). Most pricing pages blur these together. That’s why the internet feels confusing on this question.
How the three Wegovy price types work — and who actually pays each one.
Price typeWhat it isWho actually pays it
List price ($1,349.02/package)Novo Nordisk's official sticker price before any discountPatients whose insurance processes Wegovy at full retail with no coverage support
Official self-pay ($149–$399/month)Novo Nordisk's direct cash-pay pricing through NovoCare PharmacyPeople whose insurance does not cover Wegovy, plus government-insured patients who process outside insurance under NovoCare's no-reimbursement/no-deductible-credit terms
Telehealth all-inNovoCare-matched medication pricing + the telehealth provider's monthly membership feePeople who need a prescription AND ongoing clinical support
Important exclusion: Novo Nordisk’s $25 Wegovy Savings Offer is a commercial copay offer and is not available to government beneficiaries — Medicare, Medicaid, TRICARE, VA, and similar programs. NovoCare’s separate self-pay offer operates outside insurance: under its terms, a government-insured patient may use it only if the fill is not submitted for reimbursement and is not counted toward a deductible or Part D TrOOP. The CMS Medicare GLP-1 Bridge ($50 copay through CMS directly) is a separate path.

The Complete 2026 Wegovy Self-Pay Price Matrix (Verified September 21, 2026)

Answer capsule: Wegovy self-pay pricing in 2026 ranges from $149/month (low-dose pill through NovoCare or participating telehealth partners) to $399/month (Wegovy HD 7.2 mg) through the manufacturer’s direct program. Telehealth providers match that medication pricing and add a separate membership fee. The new Novo Nordisk multi-month subscription (launched March 31, 2026) drops the pen to as low as $249/month with a 12-month commitment through Ro, WeightWatchers, LifeMD, and others rolling out.

Wegovy Self-Pay Reality Matrix — Every Route Compared

Every legitimate 2026 route to brand-name Wegovy compared. Verified September 21, 2026 against primary sources. Prices can change — always confirm at checkout.
RouteFirst-month total (std pen)
✅ NovoCare Pharmacy (direct)$349
NovoCare at retail (CVS, Walgreens, Costco, 70k+ pharmacies)$349
Hers / Hims (Novo partner, March 2026)Confirm at checkout
Ro — monthly cash-pay$238 first / $498 ongoing (monthly) or $423 (annual)
Ro — 12-month subscription ⭐Confirm checkout total; the $74/mo Ro Body rate requires annual prepayment
WeightWatchers Med+ (Novo partner)Varies by commitment
LifeMD (Novo partner)~$274 on current promo
Costco Pharmacy via Sesame$349 med + Sesame subscription
GoodRx (Novo partner program)Matches NovoCare when eligible
TrumpRx (federal cash-pay platform)~$350/mo (verify current terms)
❌ Novo Nordisk PAPNot covered — see note below
Key caveats:
• *Wegovy pill 4 mg was $149/month through August 31, 2026; it is now $199/month.
• Pen intro ($199/month) for new-patient 0.25 mg or 0.5 mg doses runs through December 31, 2026.
• Government beneficiaries (Medicare, Medicaid, TRICARE, VA) are NOT eligible for Novo Nordisk’s $25 commercial copay offer. NovoCare’s separate self-pay offer may be used outside insurance under its no-reimbursement/no-deductible-credit terms. The CMS Medicare GLP-1 Bridge ($50 copay, through December 31, 2027) is a separate path.
• Novo Nordisk’s PAP does not cover Wegovy for weight loss in 2026. The PAP covers certain diabetes medications (like Ozempic) but not Wegovy. We verified this against current NovoCare program materials.
• Standard monthly medication prices often match NovoCare, but provider multi-month discounts and payment commitments can change the medication cost too. Compare the same format, dose, term, amount due now, and separate care fee.

See what you actually pay — free 2-minute check

Most readers fit one of three buckets. Here’s the cleanest next step for each:

Already have a prescription

Go straight to NovoCare Pharmacy. No membership fee, home delivery, manufacturer-direct pricing.

NovoCare Pharmacy

Not sure insurance won’t cover it?

Run Ro’s free GLP-1 coverage checker. Ro contacts your insurer and emails you a personalized report.

Check GLP-1 coverage free →

Need a doctor + medication

Pick the telehealth partner that fits your situation. Hers, Hims, Ro, Sesame, LifeMD all match NovoCare pricing.

Compare providers →

Wegovy Pill vs Pen Cost Without Insurance

Answer capsule: At standard monthly self-pay prices, the Wegovy pill has a lower maintenance-dose medication cost than the pen; introductory and prepaid offers can change the comparison. The pill starts at $149/month (1.5 mg) and is $199/month at 4 mg, topping out at $299/month (9 mg and 25 mg maintenance). The pen starts at $199/month (new-patient intro) or $349/month standard, with Wegovy HD 7.2 mg at $399/month.
Wegovy Pill vs Wegovy Pen comparison. Wegovy Pill: taken once daily, take on empty stomach with only up to 4 ounces of water, wait at least 30 minutes before food or other medications, swallow whole, store at room temperature. Wegovy Pen: used once weekly, prefilled injection pen, common injection areas are stomach, thigh, or upper arm, store in refrigerator, can be at room temperature limited time, no daily fasting routine. Both are prescription Wegovy options.

The pill requires a daily empty-stomach routine; the pen is once weekly with no fasting required. Both are FDA-approved Wegovy options from Novo Nordisk.

Wegovy pill vs pen — cost and key differences. Sources: NovoCare, Wegovy.com. Verified September 21, 2026.
FactorWegovy PenWegovy Pill
Dosing scheduleOnce weeklyOnce daily
Starter dose cash price$199/mo (intro, 0.25–0.5 mg through December 31, 2026) or $349/mo standard$149/mo (1.5 mg); $199/mo (4 mg)
Maintenance dose cash price$349 per 28-day fill at 1.7 mg or 2.4 mg; HD 7.2 mg is $399$299 per 30-day fill at 25 mg; 9 mg is an escalation dose
High-dose optionWegovy HD 7.2 mg — $399/moNot available in HD
Avg weight loss (max adult dose, clinical trial data)~15% on 2.4 mg; ~19% average on 7.2 mg HD~14% on 25 mg
StorageRefrigeratedRoom temperature
Daily-routine burdenInject once weekly, any timeEmpty stomach, ≤4 oz plain water, wait 30 min before food/drink/other oral meds
Intro offer expiry to watchDecember 31, 2026 ($199/mo pen intro)4 mg $149 offer ended August 31, 2026
Which is cheaper self-pay?$349–$399/mo$149–$299/mo ✅

When the pill makes sense for cost-driven buyers

  • Your clinician agrees the pill is clinically appropriate
  • You can reliably take it on an empty stomach before your first food of the day
  • You prefer a pill over weekly injections
  • You want the lowest self-pay cost for brand-name semaglutide

When the pen is worth the extra $50–$100/month

  • You don't want to reorganize your morning around a 30-minute fasting window
  • You want the higher-dose option (Wegovy HD 7.2 mg)
  • Your insurance is more likely to cover the pen (true for most commercial plans)

For the deep dive on pill-specific buying channels, which retail pharmacies stock the Wegovy pill, and the exact all-in math per provider, see our separate guide: Wegovy Pill Cost & Where to Buy Online.

The $25 Wegovy Savings Offer: Who It Works For (And Who It Doesn’t)

Answer capsule: The $25 Wegovy Savings Offer is a commercial-insurance copay offer and is not available to Medicare, Medicaid, TRICARE, VA, or other government-program beneficiaries. Novo Nordisk also has a separate self-pay offer for people whose insurance does not cover Wegovy or who choose to process the prescription outside insurance. Government-insured patients may use that self-pay path only under the offer’s terms: the fill cannot be submitted for reimbursement and cannot count toward a deductible or Medicare Part D TrOOP. Verify eligibility and the current price with NovoCare before filling.

The four real scenarios

Wegovy $25 Savings Offer eligibility by insurance situation. Source: NovoCare commercial copay-offer and self-pay offer terms, checked September 21, 2026.
Your situationYour likely cheapest path
Commercial insurance that covers WegovyUse the Wegovy Savings Offer ✅
Commercial insurance that excludes WegovyNovoCare self-pay ($149–$399/mo) is usually cheaper
Uninsured / self-payNovoCare direct at $149–$399/month (pen standard or pill by dose)
Medicare, Medicaid, TRICARE, VA, or another government programCheck Bridge eligibility first if you have Part D; otherwise verify the current self-pay terms with NovoCare
Worth knowing before you enroll: Novo Nordisk may modify or cancel the offer. The commercial copay offer applies after eligible insurance coverage. The separate self-pay offer operates outside insurance and does not count toward deductible or Part D TrOOP.

Don’t guess about your formulary. A free insurance check tells you in minutes whether your plan covers Wegovy and whether a prior authorization is required.

Check your GLP-1 coverage free through Ro → Ro contacts your insurer and emails a personalized report

The Cheapest Legitimate Way to Get Wegovy Without Insurance

Answer capsule: The cheapest clean path depends on whether you already have a Wegovy prescription and whether you have commercial insurance. Novo Nordisk’s Patient Assistance Program does not currently cover Wegovy for weight loss.

Case 1: You have commercial insurance that covers Wegovy

Use the Wegovy Savings Offer.

Enroll at novocare.com or text SAVE to 83757 and take the offer to your pharmacist. Eligible commercial patients may pay as little as $25 per monthly fill, with maximum savings of $100. This does not guarantee a $25 total. This is the cheapest legitimate path for anyone whose plan already includes Wegovy.

Case 2: You already have a prescription but no coverage (or a plan that excludes Wegovy)

Go straight to NovoCare Pharmacy.

No middleman, no membership fee. Two ways: (1) NovoCare Pharmacy home delivery — enroll at novocare.com, prescription ships directly. (2) NovoCare coupon at retail — take the offer to any of 70,000+ pharmacies (CVS, Walgreens, Walmart, Costco) and fill locally at the same price. You pay $149/mo (pill 1.5 mg), $199/mo (pill 4 mg), $299/mo (pill 9 mg or 25 mg), $199/mo (pen intro through December 31, 2026), $349/mo (pen standard), or $399/mo (Wegovy HD 7.2 mg).

This is the honest cheapest answer for Rx-in-hand readers. Readers who already have a prescription shouldn't pay for a telehealth membership they don't need.

Case 3: You still need a doctor AND medication

Compare the real first-month total, not just the medication price.

All three of the strongest options carry the same Novo-partner medication pricing. The differentiator is the experience: Hers — best for women who want a mainstream consumer-health brand. Hims — same offering, male-coded. Ro — best if you want someone to fight insurance first (free coverage checker, insurance concierge, prior auth support as part of membership). For the lowest locked medication price with a 12-month commitment, the Novo multi-month subscription through Ro drops the pen to $249/month flat.

Case 4: Low income and uninsured (below ~200% federal poverty level)

Novo PAP does NOT cover Wegovy for weight loss.

As of 2026, the Novo PAP covers certain diabetes medications (including Ozempic) but does NOT cover Wegovy for weight loss. We verified this directly against the current PAP covered-products list. Realistic cheapest paths for low-income uninsured patients: (1) NovoCare Pharmacy self-pay at $149/month for the pill starter — still the lowest clean brand-name price. (2) Medicare GLP-1 Bridge at $50/month launched July 1, 2026 for eligible Part D enrollees. (3) State Medicaid in one of the 13 states whose Medicaid programs currently cover GLP-1s for obesity treatment.

Hers vs Hims vs Ro vs Sesame vs LifeMD: Which Telehealth Path Fits You?

Answer capsule: All five major Novo Nordisk telehealth partners carry the same FDA-approved Wegovy at the same Novo-partner cash pricing. What differs is what each provider adds around the medication — consumer-health branding (Hers/Hims), insurance-fighting support (Ro), marketplace with Costco integration (Sesame), or hands-on clinical care (LifeMD).
Telehealth partner comparison — verified September 21, 2026. Always confirm current pricing at checkout.
FeatureHersHimsRo
FDA-approved Wegovy pen✅✅✅
FDA-approved Wegovy pill✅✅✅
Medication price baselineNovoCare matchNovoCare matchNovoCare match
12-month sub availableRolling outRolling out✅ Live ($249/mo pen)
Membership/program feeRequired; check currentRequired; check current$39 first mo, then $149/mo (or $74/mo annual prepay)
Insurance coverage checkerAvailableAvailable✅ Free, emails personalized report
Prior auth supportStandardStandard✅ Yes, as part of membership
HSA/FSAPay + submit receiptsPay + submit receipts❌ Does NOT accept HSA/FSA cards — pay + submit receipts
Costco pickup———
Best forWomen, consumer-brand app-firstMen, same structure as HersUnisex, insurance-fighting, coverage uncertain
Our single damaging admission on this page: Full-service telehealth is not the cheapest way to get brand-name Wegovy if you already have a prescription. If medication-only cost is your only priority and you already have a prescription, NovoCare Pharmacy direct at $349/month (standard pen) or $149–$299/month (pill) beats any telehealth route — because you skip the monthly membership fee.

Telehealth doesn’t beat NovoCare on medication price. It beats NovoCare on everything around the medication — evaluation, prescribing, insurance fighting, and follow-up care. If what you actually need is the whole pathway, that’s what the membership fee is buying.

Who should pick each one

Pick Hers if…

You're a woman who wants a mainstream consumer-health brand with FDA-approved Wegovy and a clean app-first flow.

Check your Hers Wegovy options →

Pick Hims if…

Same logic, male-coded. Same medication access through the March 2026 Novo partnership, same underlying pricing structure.

Check your Hims Wegovy options →

Pick Ro if…

You're not 100% sure insurance won't cover Wegovy. Ro's free GLP-1 coverage checker contacts your insurer directly and emails a personalized report. Insurance concierge included in membership.

Run Ro's free GLP-1 coverage check →

Pick Sesame (Costco path) if…

You're a Costco member. Success by Sesame gives 10% off the subscription, and once you have a prescription you can pick up Wegovy at Costco Pharmacy at NovoCare-matched pricing. Costco Executive members and Costco Anywhere Visa holders also receive 2% back on the medication.

See the Costco Pharmacy path through Sesame →

If you need a prescriber as well as medication, compare GLP-1 online programs by care fees, insurance help and the medication routes they offer.

What to Do If Coverage Was Denied, Your Deductible Is Too High, or You’re on Government Insurance

Answer capsule: Many readers searching “Wegovy cost without insurance” aren’t literally uninsured — they’re coverage-denied, on a plan that excludes weight-loss drugs, functionally cash-pay because of a high deductible, or on government insurance that doesn’t currently cover Wegovy for weight management.

If your commercial insurance denied Wegovy

Don’t accept the first denial. Appeals are a structured process, and a well-documented request succeeds more often than readers expect:

  1. 1Ask your doctor to file a formulary exception citing medical necessity (BMI criteria, weight-related conditions, cardiovascular risk)
  2. 2If denied again, request an external independent review
  3. 3While the appeal is pending, use NovoCare self-pay or the Wegovy pill ($149/month low dose) as a bridge so your weight-loss timeline doesn't stall

We maintain a separate guide: Wegovy Prior Authorization: Criteria, Forms & What to Do If Denied.

If your plan excludes weight-loss drugs entirely

Some employer plans specifically exclude weight-loss medications. Appealing won’t unlock coverage — the exclusion is the plan design. One exception: Wegovy is also FDA-approved to reduce the risk of major cardiovascular events in adults with established cardiovascular disease who are overweight or obese. Some plans that exclude weight-loss drugs will cover Wegovy under the cardiovascular indication. If you have qualifying cardiovascular history, ask your doctor whether that pathway applies.

If your deductible makes insurance useless

With a $3,000+ deductible, you’d typically pay close to full negotiated price per month until the deductible resets. NovoCare self-pay at $349/month (pen) or $149–$299/month (pill) is frequently cheaper than the deductible math.

HSA/FSA note: Most providers including NovoCare accept HSA/FSA payment at checkout. Ro is an exception — Ro does not accept HSA/FSA cards directly. You pay with a regular card and submit receipts for reimbursement. Hers and Hims recommend the same reimbursement approach.

If you’re on Medicare

Medicare GLP-1 Bridge

CMS demonstration program running July 1, 2026 – December 31, 2027. Eligible Medicare Part D enrollees can access Wegovy and Zepbound for weight management at $50/month. Eligibility: BMI ≥ 35, or BMI ≥ 27 plus other clinical criteria.

BALANCE Model status

CMS says the planned BALANCE Model will not launch in 2027; the Bridge was extended through December 31, 2027 instead. There is no BALANCE plan to select during Medicare Open Enrollment.

Medicare GLP-1 Bridge: CMS says the Bridge runs from July 1, 2026 through December 31, 2027 and operates outside the Part D payment flow. Eligible participants pay a $50 copay for covered products. CMS also says the planned BALANCE Model will not launch in 2027; the Bridge was extended instead. Eligibility, covered products, and participating pharmacies can change, so confirm them on the CMS Bridge site before acting.

If you’re on Medicaid

Medicaid coverage for Wegovy varies by state. As of January 2026, KFF identified 13 state Medicaid fee-for-service programs that cover GLP-1s for obesity treatment (usually with prior authorization). California’s Medi-Cal stopped covering Wegovy for weight management on January 1, 2026. State Medicaid rules change frequently — check your state’s Medicaid formulary directly.

If Brand-Name Wegovy Is Still Above Budget

Answer capsule: Even at $149–$349/month self-pay, Wegovy is genuinely out of reach for some readers. Three paths can get you to a lower monthly cost while staying in FDA-approved territory.

Route 1: Zepbound via LillyDirect

Eli Lilly's FDA-approved tirzepatide self-pay vials: $299/month (2.5 mg), $399/month (5 mg), $449/month (7.5–15 mg). In head-to-head trials tirzepatide produced more weight loss than semaglutide. If clinical results at a lower cost than the Wegovy pen is your priority, Zepbound is worth discussing with your clinician.

See cheapest Zepbound options

Route 2: Foundayo (orforglipron) via Ro

Eli Lilly's FDA-approved oral GLP-1, available through Ro. If the pill format matters and you want a second oral option besides Wegovy pill, Foundayo is worth considering.

Route 3: Medicare GLP-1 Bridge

$50 copay for eligible Medicare Part D enrollees, July 1, 2026–December 31, 2027. Covered above.

A note on compounded semaglutide: Compounded semaglutide is produced by compounding pharmacies under different regulations from FDA-approved medications. It is not FDA-approved, and the FDA has issued multiple warnings about dosing errors, fraudulent labels, and quality variability in compounded GLP-1 products. Compounded semaglutide is also only legally available during FDA-declared shortages. We cover compounded options on a separate page — it’s a genuinely different category, not a cheaper version of the same medication.

For a broader guide to legitimate GLP-1 paths under $200/month: GLP-1 Options Under $200 Per Month.

What the Public Review Landscape Shows

Answer capsule: Major Novo Nordisk telehealth partners have public review pages on Trustpilot and Better Business Bureau. Review themes generally cluster around service-experience factors — ease of onboarding, delivery speed, communication quality, and membership-fee transparency — rather than medication efficacy. For weight-loss efficacy specifically, Novo Nordisk’s Phase 3 trial data (STEP trials for Wegovy pen, OASIS trials for Wegovy pill) is the primary source your clinician can discuss with you.

We’ve deliberately chosen not to publish individual user quotes. Reviews on third-party platforms are not independently verified, reflect single-user experiences, and for a YMYL medication decision we’d rather point you to the actual review platforms:

When reading public reviews: weigh recency (the telehealth Wegovy market changed significantly in March 2026), look for reviews about the specific GLP-1 service (not other services the provider offers), and note that testimonials on provider-owned pages are almost always compensated — Ro publicly discloses its member testimonials are compensated.

Frequently Asked Questions

Still Not Sure Which GLP-1 Program Is Right for You?

Take our free 60-second matching quiz. Tell us your situation — insurance, budget, format preference, brand name versus alternatives — and we’ll show you the exact path that fits you, with current pricing and the specific next step.

A final note from our editorial team: We built this page because the first page of search results makes Wegovy pricing feel more complicated than it is. There are really only three numbers — list price, official self-pay, telehealth all-in — and the right answer depends on a single question: do you already have a prescription? If yes, go to NovoCare direct. If no, pick the telehealth partner that fits you. The one path to skip entirely: Wegovy through the Patient Assistance Program, because Novo’s PAP doesn’t cover Wegovy for weight loss in 2026.
Sources and verification (verified September 21, 2026)
  • NovoCare Pharmacy pen and pill pricing — novocare.com/patient/medicines/wegovy.html and NovoCare Wegovy price guide PDF
  • Official list price ($1,349.02/package) — NovoCare's list-price resource page
  • Wegovy Savings Offer: commercial copay-offer government-beneficiary exclusion and separate self-pay eligibility terms — novocare.com/eligibility/wegovy-savings-card.html
  • Ro pricing and Ro Body membership structure — ro.co/weight-loss/pricing/
  • Ro HSA/FSA policy — ro.co/faq/cost-pricing-services/
  • Ro cancellation terms (48-hour window) — ro.co/terms-of-use/
  • Novo Nordisk 3/6/12-month Wegovy subscription program — PR Newswire press release, March 31, 2026
  • Hims & Hers/Novo Nordisk partnership — Hims investor relations, March 2026
  • Hers current Wegovy pen page — forhers.com/weight-loss/wegovy-pen
  • Hims current Wegovy pen page — hims.com/weight-loss/wegovy-pen
  • Costco + Sesame pricing structure — sesamecare.com/blog/costco-half-price-ozempic-wegovy
  • WeightWatchers Med+ subscription pricing — weightwatchers.com/us/weight-loss-medication/wegovy
  • Novo PAP coverage list (Wegovy not included) — novocare.com/diabetes/help-with-costs/pap.html
  • Medicare GLP-1 Bridge (July 1, 2026–December 31, 2027; BALANCE not launching in 2027) — cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
  • Medicaid GLP-1 coverage state count — KFF Medicaid analysis, January 2026
  • California Medi-Cal Wegovy coverage change — January 1, 2026
  • HHS 2026 Federal Poverty Level tables
  • Wegovy prescribing information and boxed warning — FDA-approved label at wegovy.com
  • Ro weight-loss pricing
  • NovoCare Wegovy savings-card terms
  • Wegovy prescribing information
  • LillyDirect Zepbound terms and conditions
  • NovoCare Pharmacy eligibility
  • Zepbound savings-program terms
  • CMS Medicare GLP-1 Bridge information
  • FDA information about unapproved GLP-1 drugs

About Weight Loss Provider Guide: We are an independent comparison resource for GLP-1 telehealth providers. We do not own or operate any telehealth platform. Our editorial priority is accuracy and reader fit; affiliate relationships do not determine the order or emphasis of our recommendations. Advertising disclosure. Editorial standards.

Last verified: September 21, 2026. Next scheduled re-verification: October 21, 2026, or immediately if NovoCare or CMS changes its terms. Program terms can change at any time at the manufacturer’s discretion — verify current terms at official Novo Nordisk pages before filling your prescription.

Medical disclaimer: This article is for informational purposes only. Wegovy is a prescription medication with serious warnings. Wegovy carries a boxed warning for thyroid C-cell tumors: thyroid C-cell tumors have been observed in rodent studies at clinically relevant exposures, and it is unknown whether Wegovy causes thyroid C-cell tumors, including medullary thyroid carcinoma, in humans. Wegovy is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and in patients with a prior serious hypersensitivity reaction to semaglutide or any excipient. Other serious risks include acute pancreatitis, acute gallbladder disease, hypoglycemia, and acute kidney injury. Talk to a licensed clinician before starting any GLP-1 medication. Full prescribing information at wegovy.com.

Last verified: September 21, 2026. Pricing sections reverified periodically. For corrections or feedback, contact editorial@weightlossproviderguide.com.

Related Articles